Kashaf Tariq
Higher Degree by Research Candidate
School of Pharmacy and Biomedical Sciences
College of Health
I am a PhD candidate in medicine with expertise in the cellular and molecular mechanisms underlying immune-mediated pathology. My research focuses on understanding how our immune systems can recognise and respond to cancer, with a view towards developing new immunotherapies for patients with solid tumours, particularly head and neck cancer.
I am honoured to be awarded a Commonwealth funded Australian Government Research Training Program (RTP) scholarship to support my PhD research at Adelaide University, Australia.
I was also awarded the ANSO (Alliance of International Science Organizations) scholarship for Young Talents, which supported my postgraduate studies at University of Chinese Academy of Sciences, China.
| Language | Competency |
|---|---|
| Chinese (Mandarin) | Can speak and understand spoken |
| English | Can read, write, speak, understand spoken and peer review |
| Urdu | Can read, write, speak, understand spoken and peer review |
| Date | Institution name | Country | Title |
|---|---|---|---|
| 2025 | Adelaide University | Australia | PhD |
| 2022 - 2025 | University of Chinese Academy of Sciences | China | Master |
| Date | Title | Institution name | Country |
|---|---|---|---|
| 2026 | 2026 Peer Mentoring Training | Adelaide University | Australia |
| 2023 | UCAS International Young Scholars Summer School | University of Chinese Academy of Sciences | China |
| Year | Citation |
|---|---|
| 2025 | Tariq, H. K., Liang, Z., Rabiu, L., Ibrahim, A., Mohamady Farouk Abdalsalam, N., Li, R., . . . Yan, D. (2025). Blockade of TIPE2-Mediated Ferroptosis of Myeloid-Derived Suppressor Cells Achieves the Full Potential of Combinatory Ferroptosis and Anti-PD-L1 Cancer Immunotherapy. CELLS, 14(2), 19 pages. WoS9 |
| 2025 | Ibrahim, A., Abdalsalam, N. M. F., Liang, Z., Tariq, H. K., Li, R., Afolabi, L. O., . . . Yan, D. (2025). MDSC checkpoint blockade therapy: a new breakthrough point overcoming immunosuppression in cancer immunotherapy. CANCER GENE THERAPY, 32(4), 371-392. WoS55 |
| 2025 | Rabiu, L., Zhang, P., Liu, Z., Tang, Y., Gidado, K. I., Ibrahim, A., . . . Zhang, G. (2025). TIPE2 deficiency amplifies inflammation and immune dysregulation in MASH through modulating hepatic lipid metabolism and immune cell function. INFLAMMATION RESEARCH, 74(1), 15 pages. WoS2 |
| 2024 | Abdalsalam, N. M. F., Liang, Z., Tariq, H. K., Ibrahim, A., Li, R., Wan, X., & Yan, D. (2024). Etomoxir Sodium Salt Promotes Imidazole Ketone Erastin-Induced Myeloid-Derived Suppressor Cell Ferroptosis and Enhances Cancer Therapy. BIOLOGY-BASEL, 13(11), 15 pages. WoS6 |
| 2022 | Ashraf, M. A., Tariq, H. K., Hu, X. -W., Khan, J., & Zou, Z. (2022). Computational Biology and Machine Learning Approaches Identify Rubber Tree (<i>Hevea brasiliensis</i> Muell. Arg.) Genome Encoded MicroRNAs Targeting Rubber Tree Virus 1. APPLIED SCIENCES-BASEL, 12(24), 14 pages. WoS6 |